{"id":73307,"date":"2026-10-20T09:38:15","date_gmt":"2026-10-20T13:38:15","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/bessent-outlines-growth-strategy-for-debt-amgen-and-gm-pivot-on-product-lines\/73307\/"},"modified":"2026-10-20T09:38:15","modified_gmt":"2026-10-20T13:38:15","slug":"bessent-outlines-growth-strategy-for-debt-amgen-and-gm-pivot-on-product-lines","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/bessent-outlines-growth-strategy-for-debt-amgen-and-gm-pivot-on-product-lines\/73307\/","title":{"rendered":"Bessent Outlines Growth Strategy for Debt; Amgen and GM Pivot on Product Lines"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Treasury Secretary Scott Bessent<\/strong> asserts that <strong>3% annual economic growth<\/strong> is the primary solution to overcoming the <strong>$40 trillion<\/strong> U.S. national debt.<\/li>\n<li><strong>Amgen (<a href=\"\/stock\/AMGN\">AMGN<\/a>)<\/strong> and <strong>AstraZeneca (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> reported that their drug <strong>Tezspire<\/strong> achieved up to <strong>68.9% histologic remission<\/strong> in Phase 3 trials for eosinophilic esophagitis (EoE).<\/li>\n<li><strong>General Motors (<a href=\"\/stock\/GM\">GM<\/a>)<\/strong> CEO Mary Barra confirmed the automaker will debut <strong>hybrid vehicles<\/strong> across multiple segments, a strategic shift to meet shifting consumer demand.<\/li>\n<li><strong>Bessent<\/strong> dismissed concerns over recent volatility in the <strong>U.S. bond market<\/strong>, stating the market has &quot;done well&quot; compared to global peers despite yields hovering near <strong>5%<\/strong>.<\/li>\n<li>The Treasury Secretary remains <strong>positive on the economy<\/strong> despite short-term energy price spikes, which he characterized as a temporary &quot;shock&quot; related to geopolitical conflicts.<\/li>\n<\/ul>\n<h2>Bessent Champions Growth to Combat Rising Debt<\/h2>\n<p>U.S. Treasury Secretary <strong>Scott Bessent<\/strong> emphasized on Tuesday that the United States must prioritize aggressive economic expansion to manage its mounting fiscal obligations. Bessent stated that achieving a sustained <strong>3% growth rate<\/strong> would allow the country to &quot;grow its way out&quot; of a debt load that recently surpassed <strong>$40 trillion<\/strong>. He argued that the U.S. remains in a stronger fiscal position than many advanced economies due to its underlying economic resilience.<\/p>\n<p>Addressing recent market turbulence, Bessent noted that the <strong>U.S. bond market<\/strong> has performed admirably despite a global rise in borrowing costs. He indicated that he has observed <strong>no spillover effects<\/strong> from fiscal challenges in <strong>France<\/strong>, praising French President <strong>Emmanuel Macron&#39;s<\/strong> economic team as being of &quot;high quality.&quot; While acknowledging a recent rise in <strong>energy prices<\/strong>, Bessent maintained a positive outlook, suggesting these pressures are short-term and will ease as global supply disruptions are resolved.<\/p>\n<h2>Amgen\u2019s Tezspire Shows Strong Results in EoE Trial<\/h2>\n<p><strong>Amgen (<a href=\"\/stock\/AMGN\">AMGN<\/a>)<\/strong> and partner <strong>AstraZeneca (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> released detailed data from the Phase 3 <strong>CROSSING trial<\/strong> for <strong>Tezspire<\/strong> (tezepelumab-ekko). The trial focused on patients with <strong>eosinophilic esophagitis (EoE)<\/strong>, a chronic inflammatory condition of the esophagus. The results showed that <strong>64.8%<\/strong> of patients on a 210 mg dose and <strong>68.9%<\/strong> on a 420 mg dose achieved <strong>histologic remission<\/strong> at week 24, compared to just <strong>3.5%<\/strong> in the placebo group.<\/p>\n<p>The study also demonstrated significant improvements in <strong>dysphagia<\/strong> (difficulty swallowing) symptoms, which were sustained through <strong>52 weeks<\/strong>. This successful readout positions <strong>Tezspire<\/strong> as a potential competitor to existing treatments in the EoE market. The companies indicated that the safety profile remained consistent with the drug\u2019s currently approved indications for severe asthma and nasal polyps.<\/p>\n<h2>GM Shifts Strategy Toward Multi-Segment Hybrids<\/h2>\n<p><strong>General Motors (<a href=\"\/stock\/GM\">GM<\/a>)<\/strong> CEO <strong>Mary Barra<\/strong> announced a significant pivot in the company&#39;s product roadmap, confirming that the automaker will introduce <strong>hybrid vehicles<\/strong> in &quot;multiple segments.&quot; This move marks a departure from GM&#39;s previous exclusive focus on all-electric vehicles (EVs) in the U.S. market. Barra noted that the company is &quot;not tone deaf&quot; to customer feedback and is moving to provide the technology diversity that buyers currently demand.<\/p>\n<p>While GM remains committed to an <strong>all-electric future<\/strong> as its long-term goal, the introduction of hybrids is intended to bridge the gap as EV adoption rates fluctuate. The new hybrid models are expected to include both <strong>plug-in (PHEVs)<\/strong> and traditional hybrid configurations. Industry analysts suggest this shift will help GM compete more effectively with rivals like <strong>Toyota<\/strong>, who have seen a surge in hybrid sales amid cooling demand for pure battery-electric cars.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Treasury Secretary Scott Bessent asserts that 3% annual economic growth is the primary solution to overcoming the $40 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[6052,6287,7765,11830,18846,23315,23316],"class_list":["post-73307","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-us-treasuries","tag-scott-bessent","tag-astrazeneca-azn-stock-azn","tag-general-motors-gm-stock-gm","tag-amgen-amgn-stock-amgn","tag-hybrids","tag-eosinophilic-esophagitis"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=73307"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73307\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=73307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=73307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=73307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}